4//SEC Filing
Reid Laurence 4
Accession 0000899243-23-008873
CIK 0001656536other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:24 PM ET
Size
12.3 KB
Accession
0000899243-23-008873
Insider Transaction Report
Form 4
Reid Laurence
DirectorSee Remarks
Transactions
- Award
Common Stock
2023-03-16+195,000→ 220,849 total - Award
Stock Options (right to buy)
2023-03-16+72,000→ 72,000 totalExercise: $3.73Exp: 2033-03-15→ Common Stock (72,000 underlying)
Footnotes (3)
- [F1]Consists of shares of the Issuer's common stock issuable under 195,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. The RSUs are scheduled to vest with respect to 40% of the shares on January 26, 2024, and with respect to the remainder on January 26, 2025.
- [F2]Includes 195,000 unvested RSUs. Each unvested RSU represents the right to receive one share of the Issuer's common stock upon vesting.
- [F3]The option was granted on March 16, 2023. The shares underlying the option are scheduled to vest with respect to 40% of the shares on January 26, 2024, and with respect to the remainder on January 26, 2025.
Issuer
Decibel Therapeutics, Inc.
CIK 0001656536
Entity typeother
Related Parties
1- filerCIK 0001492749
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:24 PM ET
- Size
- 12.3 KB